CAS NO: | 1816331-66-4 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | GSK864 is anisocitrate dehydrogenase1 (IDH1) mutant inhibitor; inhibitsIDH1mutants R132C, R132H, and R132G withIC50values of 8.8, 15.2 and 16.6 nM. | ||||||||||||||||
IC50& Target | IC50: 8.8 nM (IDH1 mutants R132C), 15.2 nM (IDH1 mutants R132H), 16.6 nM (IDH1 mutants R132G)[1] | ||||||||||||||||
体外研究 (In Vitro) | GSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with an EC50of 320 nM by LCMS/MS analysis[1]. | ||||||||||||||||
体内研究 (In Vivo) | Following intraperitoneal (IP) administration in CD-1 mice, significant concentrations of GSK864 are maintained in peripheral blood samples of mice for up to 24 hours. Analysis of BM cells for expression of markers of early differentiation reveals slightly increased numbers of huCD45+CD38+cells in R132C or R132H IDH1 mutant engrafted mice treated with GSK864[1]. | ||||||||||||||||
分子量 | 558.60 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C30H31FN6O4 | ||||||||||||||||
CAS 号 | 1816331-66-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(179.02 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|